Table 4.
Pathway/mRNA | Fetal liver miRNA | Placental miRNA | r2 | P value | FDR |
---|---|---|---|---|---|
Lipid metabolism/synthesis | |||||
ACACA | – | miR-183-5p | +0.59 | 0.0096 | 0.0564 |
ACACA | – | miR-182-5p | +0.44 | 0.0305 | 0.0983 |
FASN | – | miR-185-5p | +0.39 | 0.0414 | 0.1132 |
FASN | – | miR-145-3p | -0.54 | 0.0151 | 0.0624 |
HMOX1 | – | miR-183-5p | +0.70 | 0.0036 | 0.0520 |
SREBP1 | – | miR-185-5p | +0.40 | 0.0394 | 0.1132 |
Oxidative stress | |||||
NFE2L2 | miR-1285-3p | – | -0.50 | 0.0091 | 0.0564 |
NFE2L2 | - | miR-1285-3p | +0.48 | 0.0107 | 0.0564 |
Inflammation | |||||
ICAM1 | miR-1285-3p | – | -0.63 | 0.0063 | 0.0564 |
IL10 | – | miR-183-5p | +0.45 | 0.0288 | 0.0983 |
IL10 | miR-29a-3p | – | -0.58 | 0.0104 | 0.0564 |
IL10 | miR-34a-5p | – | -0.39 | 0.0420 | 0.1132 |
IL6 | miR-1285-3p | – | +0.76 | 0.0006 | 0.0334 |
NCF4 | – | miR-182-5p | +0.48 | 0.0228 | 0.0827 |
VCAM1 | miR-1285-3p | – | -0.63 | 0.0063 | 0.0564 |
VEGFA | – | miR-185-5p | +0.59 | 0.0093 | 0.0564 |
VEGFA | – | miR-29a-3p | -0.37 | 0.0483 | 0.1167 |
Stellate cells activation and fibrosis | |||||
COL1A1 | miR-204-5p | – | +0.61 | 0.0132 | 0.0624 |
TGFB1 | – | miR-183-5p | +0.69 | 0.0036 | 0.0520 |
TGFB1 | – | miR-182-5p | +0.54 | 0.0149 | 0.0624 |
FAP | – | miR-1285-3p | -0.49 | 0.0211 | 0.0814 |
TNFSF12 | mir-183-5p | – | +0.38 | 0.0461 | 0.1163 |
Fetal liver mRNA expression was compared to placental and liver miRNA expression using ANOVA models with LASSO regularization for variable selection.